Rheumatoid Arthritis Clinical Trials in New York

Showing 2141-2160 of 4,168 trials

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

NCT03995901

A randomized controlled study to evaluate the safety, efficacy, and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.

Transplanted Organ Rejection

Talaris Therapeutics Inc.15 participantsStarted Oct 2019

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

NCT01420926

This randomized phase II trial studies how well giving decitabine with or without bortezomib works in treating older patients with acute myeloid leukemia. Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells,by stopping them from dividing, or by stopping them from spreading. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether decitabine works better when given with or without bortezomib in treating acute myeloid leukemia.

Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeTherapy-Related Acute Myeloid Leukemia

National Cancer Institute (NCI)165 participantsStarted Nov 2011

Mountain View, California, United States • Hartford, Connecticut, United States • Lewes, Delaware, United States +50 more locations

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

Rheumatoid Arthritis Trials in Other Cities

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

MPN-RC 118 AVID200 in Myelofibrosis

Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens

Higher Irradiance in Keratoconus Ectasia

Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites

Trial in Adult Subjects With Acute Migraines

Safety and Efficacy in Adult Subjects With Acute Migraines

A National Registry For Patients With Hidradenitis Suppurativa

Bacteriophage Therapy in Patients With Urinary Tract Infections

Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Expanded Access Protocol Using 131I-MIBG

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition

Other Conditions in New York